An innovation-driven medical technology company that improves lives.
Creating better together.
Introducing Enovis™, an innovation-driven growth company, initially focused on the growing orthopedic sector, and expanding to other medical technology segments over time.
Following the separation of its fabrication technology business, ESAB Corporation, in early 2022, Colfax will change its name to Enovis Corporation. Enovis symbolizes a powerful combination of innovation and vision fueled by our passion for continuous improvement and reinforced by our drive to deliver superior clinical outcomes. As we strategically pivot to a company focused on creating medical technology that improves lives, the Enovis brand emphasizes the differentiated value and accretive foresight we will bring healthcare professionals and their patients around the world.
Enovis reflects the strength of DJO and our leading positions in orthopedics combined with Colfax’s successful legacy of continuous improvement.
And, in recognition of our successful history of growth and innovation, the distinctive “O” in our new Enovis logo was deliberately carried over from our Colfax logo as it represents continuous improvement — a cornerstone of our business success that will continue at Enovis.
As part of the name change, there will be a new Enovis corporate brand identity rolled out in early 2022, which will include a new website, and the company will trade under a new symbol, ENOV. Until that time, the company will continue to trade on the New York Stock Exchange under its present symbol, CFX.